TIGIT is expressed on both activated T and NK cells and interacts with two specific DNAM-1 (CD226) ligands, CD155 (PVR) and CD112 (nectin-2), which are expressed on both immune and tumor cells [66,119,176,177]. Here, TIGIT is linked to neoplasm.